Literature DB >> 6401127

Inhibitors of ribonucleotide reductase alter DNA repair in human fibroblasts through specific depletion of purine deoxynucleotide triphosphates.

R D Snyder1.   

Abstract

Hydroxyurea, deoxyadenosine, pyridine-2-carboxaldehyde thiosemicarbazone, pyrazoloimidazole, 3,5-diamino-1,2,4 triazole (guanazole), 3,4,5-trihydroxy benzohydroxamic acid and 3,4-dihydroxy benzohydroxamic acid were examined for their effects on cellular dNTP pools, DNA excision repair, DNA replication and deoxynucleoside uptake in human diploid fibroblasts. All 7 agents were effective inhibitors of the UV excision repair process in noncycling quiescent cells, but not in rapidly dividing log-phase cells. This differential effect clearly demonstrates dependency upon modulation of cellular purine dNTP pool levels at the level of the reductase. Repair synthesis is shown to be less sensitive to all 7 reductase inhibitors than is replicative synthesis. Studies on cellular uptake of labeled DNA precursors in inhibitor-treated cells support the notion that deoxynucleosides cannot channel into the replicative synthesis process whereas they are readily utilized at repairing sites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6401127     DOI: 10.1007/BF00125567

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  36 in total

Review 1.  From deoxynucleotides to DNA synthesis.

Authors:  P Reichard
Journal:  Fed Proc       Date:  1978-01

2.  DNA damage in ultraviolet-irradiated HeLa and CHO-Kl cells examined by alkaline lysis and hydroxyapatite chromatography.

Authors:  A R Collins
Journal:  Biochim Biophys Acta       Date:  1977-10-18

3.  Inhibition of DNA repair in ultraviolet-irradiated human cells by hydroxyurea.

Authors:  A A Francis; R D Blevins; W L Carrier; D P Smith; J D Regan
Journal:  Biochim Biophys Acta       Date:  1979-07-26

4.  Differential responses of log and stationary phase human fibroblasts to inhibition of DNA repair by aphidicolin.

Authors:  R D Snyder; J D Regan
Journal:  Biochim Biophys Acta       Date:  1982-05-31

5.  Aphidicolin inhibits repair of DNA in UV-irradiated human fibroblasts.

Authors:  R D Snyder; J D Regan
Journal:  Biochem Biophys Res Commun       Date:  1981-04-30       Impact factor: 3.575

Review 6.  Models of the regulation of ribonucleotide reductase and their evaluation in intact mammalian cells.

Authors:  D Hunting; J F Henderson
Journal:  CRC Crit Rev Biochem       Date:  1982

Review 7.  Genetic effects of deoxyribonucleotide pool imbalances.

Authors:  B A Kunz
Journal:  Environ Mutagen       Date:  1982

8.  Single-strand breaks in DNA during repair of UV-induced damage in normal human and xeroderma pigmentosum cells as determined by alkaline DNA unwinding and hydroxylapatite chromatography: effects of hydroxyurea, 5-fluorodeoxyuridine and 1-beta-D-arabinofuranosylcytosine on the kinetics of repair.

Authors:  K Erixon; G Ahnström
Journal:  Mutat Res       Date:  1979-02       Impact factor: 2.433

9.  The role of deoxynucleoside triphosphate pools in the inhibition of DNA-excision repair and replication in human cells by hydroxyurea.

Authors:  R D Snyder
Journal:  Mutat Res       Date:  1984 Mar-Apr       Impact factor: 2.433

10.  Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluation.

Authors:  D Hunting; J F Henderson
Journal:  Can J Biochem       Date:  1981-09
View more
  6 in total

1.  The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2'deoxycytidine (decitabine) are differentially regulated by cell cycle progression.

Authors:  Mazin Al-Salihi; Margaret Yu; David M Burnett; Amanda Alexander; Wolfram E Samlowski; Frank A Fitzpatrick
Journal:  Epigenetics       Date:  2011-08-01       Impact factor: 4.528

2.  Phase 1 study of high-dose hydroxyurea in lung cancer.

Authors:  D Veale; B M Cantwell; N Kerr; A Upfold; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair. A phase II study in non-small-cell lung cancer.

Authors:  B M Cantwell; D Veale; C Rivett; S Ghani; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.

Authors:  E E Vokes; J A Moormeier; M J Ratain; M J Egorin; D J Haraf; R Mick; R R Weichselbaum
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Elevation of dCTP pools in xeroderma pigmentosum variant human fibroblasts alters the effects of DNA repair arrest by arabinofuranosyl cytosine.

Authors:  W C Dunn; J D Regan; R D Snyder
Journal:  Cell Biol Toxicol       Date:  1985-01       Impact factor: 6.691

6.  The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.

Authors:  P A Philip; L Kaklamanis; J Carmichael; K Tonkin; H Morrison; K Gatter; A L Harris
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.